Comprehensive Weight Management Center
Comprehensive Weight Management Center · 4747 Lincoln Mall Drive · Matteson, IL 60443
5.0· 40 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- Medically supervised weight loss
About this practice
Comprehensive Weight Management Center is a weight-loss practice in Matteson, Illinois. Its website refers to a medical weight-loss program but offers little further detail on services or clinicians. It holds a 5.0-star Google rating across 40 reviews dating to 2016, with 2 in the past year; reviewers most often mention the staff, and 2 mention results. The site doesn't name GLP-1 medications, so ask which weight-management options it currently offers.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2026-05-23. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★5.0 across 40 Google reviews. Of the 40 reviews we analyzed, 40 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
What patients like
- Friendly, helpful staff8 reviews
- Weight-loss results2 reviews
Common complaints
No negative reviews among those we analyzed.
Most recent Google reviews
Stephanie B.★★★★★2026-04-25The doctor and staff at this location are extremely kind and attentive. If you're looking for somewhere to check out on a weightloss journey, this is a solid place to start. They also have affordable glp options if you have wanted irl support.
Marlene C.★★★★★2024-01-24I’ve been coming to dr Ali for years off and on I love them I’ve went from 210 a my heaviest to now 176 and did it with the shot and pills
Tiffany M.★★★★★2023-04-08If you need to shed some pounds this is the place FOR YOU!! The Doctor is fabulous, The staff is awesome! The facility is immaculate!! A+ rating from me!
Chanel K.★★★★★2023-04-07GREAT PLACE TO GO IF YOU LOOKING TO LOSE WEIGHT AND HAVE SOME GOOD ENERGY🙂
Celia N.★★★★★2023-01-07I attended a consultation some time ago and it is very effective. He is an excellent Doctor.⭐️⭐️⭐️⭐️⭐️
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs